DRAVP ID Name Sequence Target Organism Pubmed/Patent ID
DRAVPe01608 MU89 (Octa 1 dp) RRWYRWWRRRWYRWWR HSV 17681018
DRAVPe01609 Hepta 1 RWWRWWR HSV 17681018
DRAVPe01610 MU92 (Hepta 1 dp) RWWRWWRRWWRWWR HSV 17681018
DRAVPe01611 Deca 1 YRWWRWARRW HSV 17681018
DRAVPe01612 MU94 (Deca 1 dp) YRWWRWARRWYRWWRWARRW HSV 17681018
DRAVPe01613 N-[RLLR]3 APKAMRLLRRLLRRLLR HSV 17681018
DRAVPe01614 RLLR5 RLLRRLLRRLLRRLLRRLLR HSV 17681018
DRAVPe01615 MU103 RRRRRRRWWWRRRRRRRR HSV 17681018
DRAVPe01616 MU104 RRRRRRRRRRRRRRRWWW HSV 17681018
DRAVPe01617 ApoEdpL-W WRKWRKRWWWRKWRKRWW HSV,HIV,VSV 17681018
DRAVPe01640 Alloferon-1 [H1K] KGVSGHGQHGVHG HHV,CBV2 21766388
DRAVPe01641 Alloferon-1 [H1R] RGVSGHGQHGVHG HHV,CBV2 21766388
DRAVPe01642 Alloferon-1 [H1A] AGVSGHGQHGVHG HHV,CBV2 21766388
DRAVPe01653 Peptide 2 GGVLVQPG SARS-CoV-2,HCMV,VZV 34502335
DRAVPe01654 Peptide 3 GGVLVQPG SARS-CoV-2,HCMV,VZV 34502335
DRAVPe01655 Peptide 4 GGVLVQPG SARS-CoV-2,HCMV,VZV 34502335
DRAVPe01656 Peptide 5 GVLVQ SARS-CoV-2,HCMV,VZV 34502335
DRAVPe01657 Peptide 6 GVLV SARS-CoV-2,HCMV,VZV 34502335
DRAVPe01814 Hp1036 ILGKIWEGIKSIF HSV-1 24315793
DRAVPe01815 Hp1239 ILSYLWNGIKSIF HSV-1 24315793
DRAVPe01816 Eval418 LWGEIWNTVKGLI HSV-1 29290802
DRAVPe01817 Eval418-FH2 LWGHIWNFVHGLI HSV-1 29290802
DRAVPe01818 Eval418-FH3 LWHHIWNFVHGLI HSV-1 29290802
DRAVPe01819 Eval418-FH4 LWHHIWNTVHHLI HSV-1 29290802
DRAVPe01820 Eval418-FH5 LWHHIWHTVHHLI HSV-1 29290802
DRAVPe01829 KP AKVTMTCSAS HSV-1 30654366
DRAVPe01830 K10S KKVTMTCSAS HSV-1, CoxV B5, AdV, VSV 30654366
DRAVPe01836 L12P LCLRNWDQGHRP HSV-1, CoxV B5 30654366
DRAVPe01878 Pep19-2.5 GCKKYRRFRWKFKGKFWFWG HIV, HSV-1, HCV, HBV 22457281
DRAVPe01879 Pep19-4 GKKYRRFRWKFKFGKWFWFG HIV, HSV-1, HCV 22457281
First 1 2 3 4 5 6 7 Last